Aclaris Therapeutics ACRS
- bosakitug — Atopic Dermatitis Phase 2
- ATI-052 — Atopic Dermatitis Phase 1
- ATI-052 — Asthma Phase 1
- ATI-052 — Eosinophilic Esophagitis
TSLP (4 companies · 11 programs)
Companies with an active program directed at TSLP.
Apogee Therapeutics, Inc. APGE
- APG333 Phase 1
- APG273 — Asthma Preclinical
- APG273 — Chronic Obstructive Pulmonary Disease Preclinical
Celldex Therapeutics, Inc. CLDX
- CDX-622 — Asthma Phase 1
- CDX-622 — Allergic Rhinitis
- CDX-622 — Food Allergy
Q32 Bio Inc. QTTB
- bempikibart — Alopecia Areata Phase 2